(Q47993444)

7 February 2018

title

Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas (English)

1 reference

7 February 2018

7

Per Morten Sandset

1 reference

7 February 2018

Helene F S Negaard

1

1 reference

7 February 2018

Katja Svennevig

2

1 reference

7 February 2018

Svein Olav Kolset

3

1 reference

7 February 2018

Nina Iversen

4

1 reference

7 February 2018

Inger Marie Bowitz Lothe

5

1 reference

7 February 2018

Bjørn Østenstad

6

1 reference

7 February 2018

Per Ole Iversen

8

1 reference

7 February 2018

publication date

1 June 2009

1 reference

7 February 2018

published in

Leukemia & Lymphoma

1 reference

7 February 2018

volume

50

1 reference

7 February 2018

issue

6

1 reference

7 February 2018

page(s)

998-1004

1 reference

7 February 2018

Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Conne

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Novel functions of TIMPs in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Syndecan-1 in B lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Matrix metalloproteinases: multifunctional contributors to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Generation and degradation of human endostatin proteins by various proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Angiogenesis and hemostasis in hematological neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902889270

10.1080/10428190902889270

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

release_d73ehk7rvrexpmlh55agutcywe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d73ehk7rvrexpmlh55agutcywe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 February 2018